No record found
No record found
No record found
capitalstake.com. Provided by * Returns not adjusted for payouts
^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.
Company Profile
Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.
| Syed Anis Ahmed | CEO |
| Ehsan A. Malik | Chairperson |
| Muhammad Usama Jamil | Company Secretary |
Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Hyderabad Road, Landhi, Karachi, Pakistan
FAMCO Share Registration Services (Pvt) Limited, 8-F, Next to Hotel Faran, Nursery Block 6, P.E.C.H.S, Shahrah-e-Faisal,Karachi
EY Ford Rhodes, Chartered Accountants
December
Equity Profile
Announcements
| Date | Title | Document |
|---|---|---|
| Oct 30, 2025 | Transmission of Quarterly Reports for the Period Ended September 30, 2025 | View PDF |
| Oct 29, 2025 | Financial Results for the Quarter Ended September 30, 2025 | View PDF |
| Aug 29, 2025 | Transmission of Quarterly Account for the Period Ended June 30, 2025 | View PDF |
| Aug 28, 2025 | Financial Results for the Quarter Ended June 30, 2025 | View PDF |
| Apr 30, 2025 | Transmission of Quarterly Report for the Period Ended March 31, 2025 | View PDF |
Financials
All numbers in thousands (000's) except EPS
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 68,177,197 | 55,475,270 | 49,257,722 | 42,569,856 |
| Profit after Taxation | 5,234,233 | 261,777 | 3,004,186 | 5,967,057 |
| EPS | 53.46 | 2.67 | 30.69 | 60.95 |
| Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | |
|---|---|---|---|---|
| Sales | 19,819,134 | 19,061,338 | 17,346,451 | 17,364,546 |
| Profit after Taxation | 1,822,546 | 1,943,499 | 1,599,673 | 1,809,143 |
| EPS | 18.62 | 19.85 | 16.34 | 18.48 |

Ratios
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Gross Profit Margin (%) | 28.95 | 21.36 | 29.49 | 37.76 |
| Net Profit Margin (%) | 7.68 | 0.47 | 6.10 | 14.02 |
| EPS Growth (%) | 1,902.25 | (91.30) | (49.65) | 31.56 |
| PEG | 0.01 | (1.89) | (0.30) | 0.37 |
Payouts
| Date | Financial Results | Details | Book Closure |
|---|---|---|---|
| February 20, 2025 3:45 PM | 31/12/2024(YR) | 100%(F) (D) | 16/04/2025 - 23/04/2025 |
| August 29, 2022 2:59 PM | 30/06/2022(HYR) | 150%(i) (D) | 12/09/2022 - 14/09/2022 |
| February 24, 2022 2:57 PM | 31/12/2021(YR) | 200%(F) (D) | 14/04/2022 - 21/04/2022 |
| August 27, 2021 11:10 AM | 30/06/2021(YR) | 200%(i) (D) | 10/09/2021 - 17/09/2021 |
| February 26, 2021 4:27 PM | 31/12/2020(YR) | 250%(F) (D) | 14/04/2021 - 21/04/2021 |
| August 28, 2020 12:14 PM | 30/06/2020(HYR) | 150% (i) (D) | 09/09/2020 - 16/09/2020 |
| March 2, 2020 3:11 PM | 31/12/2019(YR) | 75%(F) (D) | 20/05/2020 - 27/05/2020 |
| February 21, 2019 3:04 PM | 31/12/2018(YR) | 100%(F) (D) | 16/04/2019 - 23/04/2019 |
| August 17, 2018 3:07 PM | 30/06/2018(HYR) | 100% (D) | 04/09/2018 - 11/09/2018 |
| February 26, 2018 3:36 PM | 31/12/2017(YR) | 300% (D) | 14/04/2018 - 23/04/2018 |









Feedback
Terms of Use
https://www.psx.com.pk